Patents by Inventor Hugh Young

Hugh Young has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PAENIBACILLUS ISOLATES AND USES THEREOF
    Publication number: 20230016040
    Abstract: The present disclosure provides isolated Paenibacillus strains useful for fixing atmospheric nitrogen and enhancing crop yield, as well as inoculant compositions comprising one or more of the isolated strains, seeds that have been treated with one or more of the isolated strains, and methods of using the isolated strains to improve nitrogen content, crop yield, etc.
    Type: Application
    Filed: November 18, 2020
    Publication date: January 19, 2023
    Applicant: NOVOZYMES BIOAG A/S
    Inventors: William Nathan Cude, Hugh Young, Leah Blasiak, Kelly Leanne Rowells, Timothy Liburn, Charles Hall, Maria Tang, Charles Knight
  • KDM1A inhibitors for the treatment of disease
    Patent number: 9790195
    Abstract: Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDMIA, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: October 17, 2017
    Assignee: Imago Biosciences, Inc.
    Inventors: John M. McCall, Hugh Young Rienhoff, Jr., Michael Clare
  • KDM1A INHIBITORS FOR THE TREATMENT OF DISEASE
    Publication number: 20160257662
    Abstract: Disclosed herein are new compounds and compositions and their application as pharmaceuticals for the treatment of diseases. Methods of inhibition of KDMIA, methods of increasing gamma globin gene expression, and methods to induce differentiation of cancer cells in a human or animal subject are also provided for the treatment of diseases such as acute myelogenous leukemia.
    Type: Application
    Filed: August 6, 2014
    Publication date: September 8, 2016
    Inventors: John M. McCall, Hugh Young Rienhoff, Jr., Michael Clare